期刊名称：FREE RADICAL RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Free Radical Research aims to publish high-quality research papers, hypotheses and reviews in all areas in the fields of:
• Free radicals and other reactive species in biological,clinical, environmental and other systems
• Redox Signalling
• Antioxidants, including diet-derived antioxidants and other relevant aspects of human nutrition
• Oxidative Damage, mechanisms and measurement Manuscripts should contribute a significant advance to the field, supported by clearly-presented data and statistical analysis. Manuscripts should be as concise as possible subject to the need to present relevant background, data and methods. Reviewers are strongly encouraged to identify areas of the manuscript that could be shortened. FRR discourages papers that are purely descriptive (e.g. a catalogue of changes in antioxidant levels in a human disease or after administering a toxin to an animal). We also discourage ‘screening’ papers, such as the use of ‘total antioxidant activity’ assays to compare the antioxidant activities of plant extracts or herbal medicines including traditional medicines.
Abstracting & Indexing
Free Radical Research is currently indexed in: BIOSIS; Current Contents/Life Sciences; Eurofactor; Science Citation Index; Biochemistry and Biophysics Citation Index; Reference Update; Current Science Ltd; EMBASE/Excerpta Medica; Elsevier BIOBASE/Current Awareness in Biological Sciences (CABS); Toxicology Consulting Services; Chemical Abstracts; Index Medicus/Medline, SCOPUS; Sheffield University Biomedical Information services (SUBIS) and Food Sciences and Technology Abstracts.
Instructions to Authors
All submissions should be made online at Free Radical Research’s Manuscript Central site. New users should first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre.
Please submit the main text, together with the legends to figures and any tables, in a single file in Word for Windows (PC) format. (Manuscripts and figures that are submitted in PDF format cannot be processed for publication.) Figures for the main text, appropriately numbered but without legends, should be submitted in a PowerPoint, TIFF, or JPG file. Supplementary text, legends to supplementary figures and supplementary tables, should be submitted in an additional, single file in Word format. Supplementary figures should be submitted in a separate PowerPoint, TIFF, or JPG file. For Supplementary movie files, please see below.
4. Preparation of Manuscripts
Free Radical Research considers all manuscripts on the strict condition that they have been submitted only to Free Radical Research, that they have not been published already, nor are they under consideration for publication or in press elsewhere. Authors who fail to adhere to this condition will be charged with all costs that Free Radical Research incurs and their papers will not be published.
Research article contributions to Free Radical Research must report original research and all manuscripts will be subjected to review by referees. The following guidelines apply:
i. For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms should not be used.
ii. Each paper should have three to six keywords.
iii. Papers are accepted only in English.
iv. All the authors of a paper should include their full names, affiliations, postal addresses, telephone and fax numbers and email addresses on the cover page of manuscripts.
v. Abstracts of 100-150 words are required for all papers submitted and should precede the text of a paper. See Notes on Style.
vi. Manuscripts should be compiled in the following order: title page; abstract; keywords; main text; acknowledgments; appendixes (as appropriate); references; table(s) with caption(s) (on individual sheets); figure caption(s) (as a list).
vii. References
References should follow the Council of Biology Editors (CBE) (http://writing.colostate.edu/references/sources/cbe/index.cfm) style. Only works actually cited in the text should be included in the references. Indicate in the text with arabic numbers inside square brackets. Spelling in the reference list should follow the original. References should then be listed in numerical order at the end of the article
Journal article:
[1] Steiner U, Klein J, Eiser E, Budkowski A, Fetters LJ. Complete wetting from polymer mixtures. Science 1992;258:1122–1129.
Book chapter:
[2] Kuret JA, Murad F. Adenohypophyseal hormones and related substances. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon; 1990. p 1334–1360.
Conference proceedings:
[3] Irvin AD, Cunningham MP, Young AS, editors. Advances in the control of Theileriosis. International Conference held at the International Laboratory for Research on Animal Diseases; 1981 Feb 9-13; Nairobi. Boston: Martinus Nijhoff Publishers; 1981. 427 p.
Dissertations or Thesis:
[4] Mangie ED. A comparative study of the perceptions of illness in New Kingdom Egypt and Mesopotamia of the early first millennium [dissertation]. Akron (OH): University of Akron; 1991. 160 p. Available from: University Microfilms, Ann Arbor MI; AAG9203425.
Journal article on internet:
[5] Loker WM. "Campesinos" and the crisis of modernization in Latin America. Jour of Pol Ecol [serial online] 1996; 3(1). Available: http://www.library.arizona.edu/ej/jpe/volume_3/ascii-lokeriso.txt via the INTERNET. Accessed 1996 Aug 11.
Webpage:
[6] British Medical Journal [Internet]. Stanford, CA: Stanford Univ; 2004 July 10 - [cited 2004 Aug 12]; Available from: http://bmj.bmjjournals.com/
Internet databases:
[7] Prevention News Update Database [Internet]. Rockville (MD): Centers for Disease Control and Prevention (US), National Prevention Information Network. 1988 Jun - [cited 2001 Apr 12]. Available from: http://www.cdcnpin.org/db/public/dnmain.htm
viii. Section headings should be concise and numbered sequentially, using a decimal system for subsections.
ix. Authors must adhere to SI units.
x. For information on submitting animations, movie files and sound files or any additional information including indexes and calendars please click here.
xi. When using a word which is or is asserted to be a proprietary term or trade mark authors must use the symbol ® or TM or alternatively a footnote can be inserted using the wording below:
This article includes a word that is or is asserted to be a proprietary term or trade mark. Its inclusion does not imply it has acquired for legal purposes a non-proprietary or general significance, nor is any other judgement implied concerning its legal status.
5. Ethics and Consent
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patientsnames, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively.
Identifying information should not be published in written descriptions, photographs, and pedigrees, unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.
6. Disclosure of Potential Conflicts of Interest
It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership) that may affect the conduct or reporting of the work submitted. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure. Information about potential conflict of interest should be clearly stated at the point of submission (for example in a cover letter, or where available within the appropriate field on the Journal’s Manuscript Central site). This may be made available to reviewers and may be published with the manuscript at the discretion of the Editors.
7. Disclosure of Sources of funding
All sources of funding for research are to be explicitly stated, at the point of submission. This may be published with the manuscript at the discretion of the Editors.
8. Authorship Contributions
Contributions must be substantial in order to warrant authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. All other contributors should be listed as acknowledgements.
9. Colour Charges
Any figure submitted as a colour original will appear in colour in the Journal online edition free of charge and can be downloaded. Paper copy colour reproduction will only be considered on condition that authors contribute to the associated costs. The charges are £500/US$1010 for the first colour page and £250/US$515 for each colour page after per article.
There are no charges for non-colour pages.
10. Proofs
The Editor reserves the right to proceed to press without submitting page proofs to the author. However, usual practice will involve corresponding authors receiving email notification with a password and Web address from which to download a PDF. Hard copies of proofs will not be mailed. To avoid delays in publication, corrections to proofs must be returned within 48 hours, by electronic transmittal, fax or mail. Authors will be charged for excessive correction at this stage of production.
If authors do not return page proofs promptly, the Editor reserves the choice to either delay publication to a subsequent issue or to proceed to press without author corrections.
11. Offprints and Reprints
Corresponding authors will receive free online access to their article through our website (www.informahealthcare.com). Reprints of articles published in this journal can be purchased through Rightslink® when proofs are received. If you have any queries, please contact our reprints department at jenn.kane@informausa.com.
12. Copyright
It is a condition of publication that authors assign copyright or license the publication rights in their articles, including abstracts, to Informa UK Ltd. This enables us to ensure full copyright protection and to disseminate the article, and the Journal, to the widest possible readership in print and electronic formats as appropriate. Authors may, of course, use the article elsewhere after publication without prior permission from Informa UK Ltd., provided that acknowledgement is given to the Journal as the original source of publication, and that Informa Healthcare is notified so that our records show that its use is properly authorised. Authors retain a number of other rights under the Informa UK Ltd. rights policies documents.
Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.
A copyright agreement form can be downloaded by corresponding authors of accepted manuscripts with proofs. This should be signed and returned to Informa Healthcare.
For more information, please see Author Resources.
13. NIH Public Access Policy
In consideration of the National Institutes of Health (NIH) and Wellcome Trust Public Access Policies, Informa Healthcare acknowledges that the broad and open dissemination of NIH/Wellcome-funded research benefits future scientific endeavour. Because we value the contribution our journals make to the body of scientific knowledge, our policies accommodate authors who wish to submit to PubMed Central/UK PubMed Central.
- Informa Healthcare will deposit funded work to PubMed Central/UK PubMed Central for public access posting 12 months (NIH) or 6 months (Wellcome Trust) after final publication in electronic form.
- 'Funded work' shall be defined as the final, peer-reviewed manuscript that is accepted by the Editorial Office of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services.
- This embargo period begins the day the work is published online at www.informahealthcare.com.
14. Contacting the Publisher
Free Radical Research
Informa Healthcare
5th Floor
Telephone House
69-77 Paul Street
London
EC2A 4LQ, UK
Tel: (+44) 207 017 4303
Fax: (+44) 207 017 6914
Email (Please include the Journal name in all correspondence.)
Editorial Board
Editors-in-Chief:
Michael Davies - Heart Research Institute, Faculty of Medicine, University of Sydney, 7 Eliza Street
Newtown, Sydney, NSW 2042, Australia, Tel: +61 2 8208 8900, Fax: +61 2 9565 5584
Helmut Sies- Institut für Physiologische Chemie I, Heinrich-Heine Universität, Postfach 101007, D-40001 Düsseldorf, Germany. Tel: +49 211 811270; Fax: +49 211 8113029
Associate Editors:
Tilman Grune- Heinrich Heine University, Duesseldorf, Germany
Jeffrey N. Keller - Basic Research, Hibernia National Bank / Pennington Biomedical Research Center, Baton Rouge, USA
Frank Kelly- School of Health and Life Sciences Franklin Wilkins Building, King's College London, UK
Shinya Toyokuni - Graduate School of Medicine, Nagoya University, Nagoya, Japan
Reviews Editors:
Christian Schoneich - Department of Pharmaceutical Chemistry, University of Kansas, Kansas, USA
Editorial Board:
Takaaki Akaike - Kumamoto
Angelo Azzi - Boston
Enrique Cadenas - Los Angeles
Kevin Croft - Perth
Chris Cooper - Colchester
Helen Griffiths - Birmingham
Malcolm J. Jackson - Liverpool
Dean Jones - Atlanta
Lars-Oliver Klotz - Dusseldorf
Santiago Lammas - Madrid
Joao Laranjinha - Coimbra
Giovanni E. Mann - London
Mike Murphy - Cambridge
William Orr - Dallas
Henrik E. Poulsen- Copenhagen
Holly van Remmen - San Antonio
Jeremy Spencer - Reading
Young-Joon Surh - Seoul
José Vina- Valencia
| 
